{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:19:48Z","timestamp":1793697588191,"version":"4.5.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ophtha.2026.07.015","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T15:51:56Z","timestamp":1784908316000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Eye-Preserving Therapies for Early cT3c Retinoblastoma"],"prefix":"10.1016","author":[{"given":"Zhenyu","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6235-1744","authenticated-orcid":false,"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5650-4628","authenticated-orcid":false,"given":"Min","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zining","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3637-685X","authenticated-orcid":false,"given":"Reyizha","family":"Mengjiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiwei","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6642-7451","authenticated-orcid":false,"given":"Renbing","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9394-3969","authenticated-orcid":false,"given":"Xianqun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2026.07.015_bib1","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0140-6736(11)61137-9","article-title":"Retinoblastoma","volume":"379","author":"Dimaras","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ophtha.2026.07.015_bib2","article-title":"Retinoblastoma","volume":"1","author":"Dimaras","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ophtha.2026.07.015_bib3","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/01.icu.0000193079.55240.18","article-title":"Basic understanding of current classification and management of retinoblastoma","volume":"17","author":"Shields","year":"2006","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.07.015_bib4","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1016\/j.ophtha.2006.06.018","article-title":"The International Classification of Retinoblastoma predicts chemoreduction success","volume":"113","author":"Shields","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2026.07.015_bib5","series-title":"AJCC Cancer Staging Manual","first-page":"819","article-title":"Retinoblastoma","author":"Mallipatna","year":"2017"},{"key":"10.1016\/j.ophtha.2026.07.015_bib6","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.ophtha.2022.04.022","article-title":"Metastatic death based on presenting features and treatment for advanced intraocular retinoblastoma","volume":"129","author":"Tomar","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2026.07.015_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ohc.2004.11.003","article-title":"Intraocular retinoblastoma: the case for a new group classification","volume":"18","author":"Linn Murphree","year":"2005","journal-title":"Ophthalmol Clin North Am"},{"key":"10.1016\/j.ophtha.2026.07.015_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.05.005","article-title":"Conservative management of retinoblastoma: challenging orthodoxy without compromising the state of metastatic grace. \u201cAlive, with good vision and no comorbidity\u201d","volume":"73","author":"Munier","year":"2019","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ophtha.2026.07.015_bib9","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1001\/archopht.1996.01100140539004","article-title":"Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma","volume":"114","author":"Kingston","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.07.015_bib10","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1200\/JCO.2010.32.5332","article-title":"Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis","volume":"29","author":"Zhao","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ophtha.2026.07.015_bib11","first-page":"1856","article-title":"Preservation of retinoblastoma group E eyes with neovascular glaucoma using intravenous chemotherapy: risk factors and outcomes","volume":"103","author":"Rao","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.07.015_bib12","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.3390\/cancers13246240","article-title":"Retinoblastoma survival following primary enucleation by AJCC Staging","volume":"13","author":"Zhao","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ophtha.2026.07.015_bib13","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1001\/jamaophthalmol.2016.0244","article-title":"Intra-arterial chemotherapy for retinoblastoma: a systematic review","volume":"134","author":"Yousef","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.07.015_bib14","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S2352-4642(23)00141-4","article-title":"Intravenous versus super-selected intra-arterial chemotherapy in children with advanced unilateral retinoblastoma: an open-label, multicentre, randomised trial","volume":"7","author":"Wen","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.ophtha.2026.07.015_bib15","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0161-6420(87)33537-7","article-title":"Prevalence and mechanisms of secondary intraocular pressure elevation in eyes with intraocular tumors","volume":"94","author":"Shields","year":"1987","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2026.07.015_bib16","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S2352-4642(23)00165-7","article-title":"Eye-preserving therapy for retinoblastoma: new evidence and future perspectives","volume":"7","author":"Chantada","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.ophtha.2026.07.015_bib17","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/MPH.0b013e3181923cc5","article-title":"Some clinical findings at presentation can predict high-risk pathology features in unilateral retinoblastoma","volume":"31","author":"Chantada","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.ophtha.2026.07.015_bib18","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.oret.2020.02.015","article-title":"Impact of systemic chemotherapy and delayed enucleation on survival of children with advanced intraocular retinoblastoma","volume":"4","author":"Zhao","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.ophtha.2026.07.015_bib19","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1200\/JCO.18.00141","article-title":"Delayed enucleation with neoadjuvant chemotherapy in advanced intraocular unilateral retinoblastoma: AHOPCA II, a prospective, multi-institutional protocol in Central America","volume":"37","author":"Luna-Fineman","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ophtha.2026.07.015_bib20","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/jamaophthalmol.2015.2243","article-title":"Enucleation vs ophthalmic artery chemosurgery for advanced intraocular retinoblastoma: a retrospective analysis","volume":"133","author":"Yannuzzi","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.07.015_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26270","article-title":"Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation","volume":"64","author":"Berry","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ophtha.2026.07.015_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ohc.2004.11.002","article-title":"Chemotherapy for retinoblastoma","volume":"18","author":"Chan","year":"2005","journal-title":"Ophthalmol Clin North Am"},{"key":"10.1016\/j.ophtha.2026.07.015_bib23","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ophtha.2008.10.014","article-title":"Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes","volume":"116","author":"Shields","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2026.07.015_bib24","doi-asserted-by":"crossref","first-page":"150.e1","DOI":"10.1016\/j.jaapos.2020.12.006","article-title":"Intra-arterial chemotherapy for retinoblastoma in 341 consecutive eyes (1,292 infusions): comparative analysis of outcomes based on patient age, race, and sex","volume":"25","author":"Shields","year":"2021","journal-title":"J AAPOS"},{"key":"10.1016\/j.ophtha.2026.07.015_bib25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajo.2021.09.026","article-title":"Contemporary update of retinoblastoma in China: three-decade changes in epidemiology, clinical features, treatments, and outcomes","volume":"236","author":"Luo","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.07.015_bib26","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.ophtha.2014.01.026","article-title":"Intra-arterial chemotherapy for retinoblastoma in 70 eyes","volume":"121","author":"Shields","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2026.07.015_bib27","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1097\/IAE.0b013e318295f783","article-title":"Management of advanced retinoblastoma with intravenous chemotherapy then intra-arterial chemotherapy as alternative to enucleation","volume":"33","author":"Shields","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2026.07.015_bib28","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1200\/JCO.1997.15.3.1183","article-title":"Orbital development in long-term survivors of retinoblastoma","volume":"15","author":"Kaste","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ophtha.2026.07.015_bib29","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2011.03.013","article-title":"Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis","volume":"118","author":"Suzuki","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2026.07.015_bib30","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/S0161-6420(94)31182-1","article-title":"Visual outcomes of macular retinoblastoma after external beam radiation therapy","volume":"101","author":"Weiss","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2026.07.015_bib31","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1136\/bjophthalmol-2013-303694","article-title":"Visual outcomes following intraophthalmic artery melphalan for patients with refractory retinoblastoma and age appropriate vision","volume":"97","author":"Tsimpida","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.07.015_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108495","article-title":"Diseases of the corneal endothelium","volume":"205","author":"Jeang","year":"2021","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ophtha.2026.07.015_bib33","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0039-6257(75)90002-8","article-title":"Corneal edema: cause and treatment","volume":"20","author":"Levenson","year":"1975","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.07.015_bib34","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.ophtha.2007.12.014","article-title":"A phase I\/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma","volume":"115","author":"Abramson","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2026.07.015_bib35","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1001\/jamaophthalmol.2015.3108","article-title":"Treatment of retinoblastoma in 2015: agreement and disagreement","volume":"133","author":"Abramson","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.07.015_bib36","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/0002-9394(89)90116-5","article-title":"The role of cryotherapy in the management of retinoblastoma","volume":"108","author":"Shields","year":"1989","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.07.015_bib37","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/ICU.0000000000000091","article-title":"Targeted retinoblastoma management: when to use intravenous, intra-arterial, periocular, and intravitreal chemotherapy","volume":"25","author":"Shields","year":"2014","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.07.015_bib38","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/archopht.1996.01100140590011","article-title":"Penetration of chemotherapy into vitreous is increased by cryotherapy and cyclosporine in rabbits","volume":"114","author":"Wilson","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.07.015_bib39","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/ceo.12559","article-title":"Aflibercept for the treatment of neovascular glaucoma","volume":"43","author":"SooHoo","year":"2015","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.07.015_bib40","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1097\/IAE.0000000000002339","article-title":"Intravitreal anti-vascular endothelial growth factor for the management of neovascularization in retinoblastoma after intravenous and\/or intraarterial chemotherapy: long-term outcomes in a series of 35 eyes","volume":"39","author":"Stathopoulos","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2026.07.015_bib41","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.oret.2025.10.007","article-title":"Lack of long-term benefit from anti-VEGF combined therapy in cT2b retinoblastoma","volume":"10","author":"Shi","year":"2026","journal-title":"Ophthalmol Retina"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016164202600518X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016164202600518X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T03:53:19Z","timestamp":1789530799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016164202600518X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":41,"alternative-id":["S016164202600518X"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2026.07.015","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eye-Preserving Therapies for Early cT3c Retinoblastoma","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2026.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Ophthalmology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}